Home > News > Biophan to Present Today at the Convergence Drug Device Summit
March 21st, 2005
Biophan to Present Today at the Convergence Drug Device Summit
Biophan Technologies, Inc., a developer of next-generation biomedical technology, has announced that John Lanzafame, President of Nanolution, the drug delivery division of Biophan Technologies, is presenting at the Convergence Drug Device Summit commencing today in Pittsburgh, PA.
New method allows for greater variation in band gap tunability: The method can change a material's electronic band gap by up to 200 percent January 31st, 2015
Evidence mounts for quantum criticality theory: Findings bolster theory that quantum fluctuations drive strange electronic phenomena January 30th, 2015
Everything You Need To Know About Nanopesticides January 30th, 2015
DNA nanoswitches reveal how life's molecules connect: An accessible new way to study molecular interactions could lower cost and time associated with discovering new drugs January 30th, 2015